The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

There was a net loss of hospital-based obstetric care in both rural and urban U.S. hospitals from 2010 to 2022.

The novel vaccines are currently being investigated in 2 separate parallel, randomized, modified double-blind, multiarm phase 1/2 clinical studies. The FDA has granted Fast Track designation to 2 ...

Maintaining ideal cardiovascular health may lower the risk for all-cause mortality among patients with arthritis.

Dupilumab treatment improves signs and symptoms of atopic dermatitis (AD) with or without asthma and allergic rhinitis in young children.

The US Preventive Services Task Force recommends cervical cancer screening for those aged 21 to 29 years and 30 to 65 years.

A new study finds that specific pesticides are associated with an increased risk for rheumatoid arthritis among older adults.

The FDA has approved a new dosing regimen for Acetadote (n-acetylcysteine for injection), an antidote for acetaminophen ...

Prior authorization requirements can be harmful to cancer patients and place additional burdens on medical practices, survey results suggest.

Spinal symptoms and mobility improved among patients with axSpA and non-axSpA CBP over 2 years, though impairments remained, particularly in non-axSpA CBP.

HCT, the addition of itacitinib to standard GvHD prophylaxis is well tolerated and results in low rates of CRS.

HealthDay News — Celiac disease is associated with an increased risk for developing alopecia areata, according to a letter to the editor published online Nov. 21 in the Journal of the American Academy ...